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SUPPLEMENTAL FIGURE LEGENDS 
Fig. S1: AFM micrographs showed no fibril formation of Aβ42 wt and Aβ42 G33A when 
co-incubated with the AIP. Both Aβ42 wt and Aβ42 G33A co-incubated with AIP 
were present as oligomeric and globular structures (scale bar = 100 nm). Without 
AIP (scale bar = 800 nm) Aβ42 formed mature fibrils after 24 hours incubation, while 
there was no difference between Aβ42 G33A incubated with or without AIP. Solely 
oligomeric and globular structures were detected for Aβ42 G33A after 24 hours 
incubation. 
Fig. S2: Effects of D-AIP on Aβ42 wt aggregation. (A) TEM analyses showed that Aβ42 wt 
aggregation was inhibited by D-AIP. Scale bar = 100 nm. (B) SEC analyses of aggregation 
behavior of Aβ42 wt peptides co-incubated with AIP for 0, 4 or 8 hours. Aβ42 wt peptides 
were mainly present as tetra-/hexamers, which slightly increased in size after 8 hours of 
incubation. (C) SH-SY5Y cells were treated for 12 hours with 4- or 8-hour preincubated 
Aβ42 wt peptide, in the presence and absence of D-AIP, and the cell viability was determined 
using MTT assay. Co-incubation with AIP neutralized Aβ42 wt-induced neurotoxic effects, 
while AIP itself was non-toxic. The graph depicts the mean ± SEM of viability expressed as a 
%, normalized to vehicle-treated cells. *** p<0.001, One-way ANOVA followed by Dunnett’s 
multiple comparison post-hoc test was performed (D-AIP treatment as control). Number of 
independent experiments: Aβ42 4 h, n = 7; Aβ42 + AIP 4 h, n = 9; Aβ42 8 h, n = 12; Aβ42 + 
AIP 8 h, n = 13; AIP, n = 3.  
Fig. S3: Possible poses of L-AIP to Aβ42 and Aβ42 G33A docking. (A) L-AIP-Aβ42 
complex obtained from flexible docking, top pose #6. L-AIP is in green sticks representation 
with nitrogen colored in blue, oxygen in red and hydrogens of polar side chains involved in H-
bonds (dashed lines) in yellow. Gly33 and Gly37 are in red and marked with arrows, and 
Asp23 in black. Sulfur of Met35 is colored yellow. Visible N- and C-termini and interacting 
residue are shown in normal font for Aβ42 and in italics for L-AIP. In the inset, Aβ42 is 
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depicted in surface representation (in gray) and Gly33 and Gly37 in red, Asp23 in black and 
Met35-sulfur in yellow. (B) AIP-Aβ42 G33A complex obtained from flexible docking, top two 
poses. L-AIP is in green sticks representation with nitrogen colored in blue, oxygen in red 
and hydrogens of polar side chains involved in H-bonds (dashed lines) in yellow. Ala33 is in 
magenta and Gly37 in red and marked with arrows, and Asp23 in black. Sulfur of Met35 is 
colored yellow. Visible N- and C-termini and interacting residues are in normal font for Aβ42 
G33A and in italics for L-AIP. In the inset Aβ42 G33A is depicted in surface representation (in 
gray) and Ala33 in magenta, Gly37 in red, Asp23 in black and Met35-sulfur in yellow.  
Fig. S4: Preferred poses of L-AIP to Aβ42 and Aβ42 G33A docking. (A-F) L-AIP-Aβ42 
complexes obtained from flexible docking, top six poses. L-AIP is in green sticks 
representation with nitrogen colored in blue, oxygen in red and hydrogens of polar side 
chains in white. Aβ42 is depicted in surface representation (in gray) and Gly33 and Gly37 in 
red, Asp23 in black and Met35 sulfur in yellow. N- and C-termini of Aβ42 are marked with N 
or C. (G-I) L-AIP-Aβ42 G33A complexes obtained from flexible docking, top three poses. L-
AIP is in green sticks representation with nitrogen colored in blue, oxygen in red and 
hydrogens of polar side chains in white. Aβ42G33A is depicted in surface representation (in 
gray) and Ala33 in magenta, Gly37 in red, Asp23 in black and Met35 sulfur in yellow. N- and 
C-termini of Aβ42G33A are marked with N or C. 
Fig. S5: Preferred poses of D-AIP to Aβ42 docking. (A-G) D-AIP-Aβ42 complexes 
obtained from flexible docking, top seven poses. D-AIP is in green sticks representation with 
nitrogen colored in blue, oxygen in red and hydrogens of polar side chains in white. Aβ42 is 
depicted in surface representation (in gray) and Gly33 and Gly37 in red, Asp23 in black and 
Met35-sulfur in yellow. N- and C-termini of Aβ42 are marked with N or C.  
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